Article
Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?
Trends in molecular medicine - 1 Oct 2015
Brouwers Martijn C G J, Jacobs Chantal, Bast Aalt, Stehouwer Coen D A, Schaper Nicolaas C
Abstract excerpt
The continuous search for drugs targeting type 2 diabetes mellitus (T2DM) has led to the identification of small molecules that disrupt the binding between glucokinase and glucokinase regulatory protein (GKRP). Although mice studies are encouraging, it will take years before these disruptors can be introduced to T2DM patients. Recently, genome-wide association studies (GWASs) have shown that variants in the gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
